New cancer Drug's side effect on common meds revealed
NCT ID NCT06494761
First seen Jan 07, 2026 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study looked at how taking multiple doses of zongertinib changes the way the body processes three other drugs: midazolam, omeprazole, and repaglinide. Sixteen healthy men took these drugs alone and then again while on zongertinib. The goal was to see if zongertinib affects their levels in the blood, which helps doctors adjust doses for future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
Conditions
Explore the condition pages connected to this study.